Evidence map›Paper›PMID 28352173›Full record

ArticleInternational journal of nanomedicine2017

Lipid-coated iron oxide nanoparticles for dual-modal imaging of hepatocellular carcinoma.

Jinying Liang, Xinxin Zhang, Yunqiu Miao, Juan Li, Yong Gan

Abstract read
In one paragraph

Article in International journal of nanomedicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Biocompatible Poly(acrylic acid-ACS applied materials & interfaces · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Use of magnetic fields and nanoparticles to trigger drug release and improve tumor targeting.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2019
    Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jinying LiangDepartment of Pharmaceutics, China Pharmaceutical University, Nanjing, People's Republic of China; Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, People's Republic of China; School of Pharmacy, Xinxiang Medical University, Xinxiang, People's Republic of China.
Xinxin ZhangShanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, People's Republic of China.
Yunqiu MiaoShanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, People's Republic of China.
Juan LiDepartment of Pharmaceutics, China Pharmaceutical University, Nanjing, People's Republic of China.
Yong GanShanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of noninvasive imaging techniques for the accurate diagnosis of progressive hepatocellular carcinoma (HCC) is of great clinical significance and has always been desired. Herein, a hepatocellular carcinoma cell-targeting fluorescent magnetic nanoparticle (NP) was obtained by conjugating near-infrared fluorescence to the surface of Fe

Indexed as

AnimalsCarcinoma, HepatocellularFerric CompoundsFluorescenceHepatocytesHumansLipidsLiver NeoplasmsMagnetic Resonance ImagingMagnetite NanoparticlesMice, Inbred BALB CXenograft Model Antitumor AssaysFerric Compoundsferric oxideLipidsMagnetite Nanoparticlesdual-imaginghepatocellular carcinomamagnetic resonance imagingtumor-targeting

Identifiers

PMID28352173
PMCPMC5358985

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.